The CIMIT Forum Summer Education Series offers attendees the opportunity to build a greater understanding of how Inhalation Technology can help reduce human suffering and eventually health care costs. Respiratory diseases, from infections to obstructive lung disease to cancer, are major public health problems. Acute respiratory infections are the third largest cause of death worldwide. The CIMIT Inhalation Technology Program aims to develop technologies that can be used in the diagnosis and treatment of both acute and chronic respiratory and non-respiratory ailment. The respiratory tract can be used not only for local delivery but also as a conduit to deliver therapeutic agents systemically for the treatment of non-respiratory diseases and as a "window" for monitoring biomarkers of disease states.
The Series includes leaders in the field, research presentations and panel discussions. Audience interaction, cross-disciplinary fertilization, and graduate students / post-doctoral fellows attendance are strongly encouraged. All programs are free and from 4 to 6 PM at the MIT McGovern Center.
July 7, 2009:
* Inhalation Technology Overview: Advances, SetbacksJoseph Brain, SD: Harvard
* Engineering Devices and Inhalers for Particle DeliveryAnthony J. Hickey, PhD, DSc: University of North Carolina
July 14, 2009:
* Inhalation Technology for Obstructive Lung Disease Gabriela Apiou, PhD: AirLiquide
* Current clinical needs: Opportunities and challenges Gerald Smaldone, MD, PhD: SUNY Stony Brook
July 21, 2009:
* Xenon AnesthesiaPhillipe Richebe, MD, PhD: University of Washington
* Clinical Challenges of Xenon Anesthesia: Pros and Cons Thomas Marx, MD: Air Liquide
July 28, 2009
* Tissue EngineeringElazer Edelman, MD, PhD: MIT
Additional information is available at: http://www.cimit.org/forum-educationseries.html